IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Naringenin: A potential anticancer drug
- Zhang Y. , et al.
2. Cyclic nucleotide phosphodiesterases as drug targets
- Kelly M.P. , et al.
3. PRDX1 depletion predisposes to ferroptosis through inhibiting the cAMP pathway in B-cell acute lymphoblastic leukemia
- Zhong F.F. , et al.
4. Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors
- Wang M. , et al.